Mainland China

Xinhua Silk Road: 2025 Panda Carnival Gala in SW. China's Chengdu highlights conservation gains and cultural ties

BEIJING, Nov. 25, 2025 /PRNewswire/ -- The 2025 Panda Carnival Gala, an inaugural segment of the Global Panda Partners Conference 2025, opened on the evening ofNovember 21 in Chengdu, capital of southwest China's Sichuan Province , to showcase advances in giant panda conservation, promote panda-ce...

2025-11-25 09:59 902

Xinhua Silk Road: Clay whistles enliven intangible cultural heritage in E. China urban district

BEIJING, Nov. 25, 2025 /PRNewswire/ -- In a local community of Xuecheng District in Zaozhuang City, Guo Hongyan, a master of local clay whistle making, rekindled recently people's interest in handmade clay whistles with an interactive voluntary teaching activity. Guo, also an intangible cultural...

2025-11-25 09:35 776

Qingdao VR conference fuels innovation, industry growth

QINGDAO, China, Nov. 24, 2025 /PRNewswire/ -- A report from China Daily.  The 2025 Qingdao Virtual Reality Innovation Conference was held in the Laoshan district ofQingdao city, Shandong province, from Nov 21 to 22. It gathered innovators, industry leaders, researchers, and scholars to explore ne...

2025-11-25 09:00 1258

EPWK Holdings Ltd. Announces Receipt of Nasdaq Delisting Notification Letter

XIAMEN, China, Nov. 24, 2025 /PRNewswire/ -- EPWK Holdings Ltd. (Nasdaq: EPWK) (the "Company"), a company that connects businesses with great talents through innovative and efficient cloud-sourcing platforms, today announced that the Company received a letter (the "Notification Letter") from the ...

2025-11-25 05:30 768

HKeyBio Launches the HKEY-AIDMD 3.0--a Next-Generation Platform to Crack the Toughest Challenge in Autoimmune and Allergy Drug Development: Multi-target Combination Strategy Optimization

* The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBio has established four-dimensional (4D) model pools that simulate clinical heterogeneity, providing a mechanism-driven model selection platf...

2025-11-25 00:30 1209

Chartmetric Integrates NetEase Cloud Music Charts, Offering Global Industry Deeper Insight into China's Streaming Landscape

HANGZHOU, China, Nov. 24, 2025 /PRNewswire/ -- Chartmetric has integrated chart data from NetEase Cloud Music, one ofChina's largest and most youth-driven streaming platforms. The move gives global music professionals structured access to regional listening trends, helping bridge the data gap bet...

2025-11-24 23:00 1390

Appotronics' Laser Searchlight Elevates Signature Visuals for National Games Closing Ceremony, Sets Stage for Global Debut at ISE 2026

SHENZHEN, China, Nov. 24, 2025 /PRNewswire/ -- Appotronics (688007.SH), the inventor of ALPD® laser display technology, delivered the pivotal visual technology that defined the closing ceremony of the 15th National Games ofChina . Held at the Shenzhen Qianhai Happy Theater, the ceremony leveraged ...

2025-11-24 22:00 1031

Xinhua Silk Road: Minhang District in E. China's Shanghai strives to boost dev't of featured coffee industry

BEIJING, Nov. 24, 2025 /PRNewswire/ -- Minhang District in east China's Shanghai Municipality has striven to build a coffee hub and cultural streets highlighting both Minhang style andShanghai style, by gathering coffee shops within the district and blending coffee culture and daily life into a ...

2025-11-24 21:55 1224

Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint

CHENGDU, China, Nov. 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study (OptiTROP-Lung05) of the company's TROP2 ADC sacituzumab tiru...

2025-11-24 20:00 1106

Qudian Inc. Reports Third Quarter 2025 Unaudited Financial Results

XIAMEN, China, Nov. 24, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company inChina, today announced its unaudited financial results for the quarter endedSeptember 30, 2025. Third Quarter 2025 Financial Highlights: * Total re...

2025-11-24 18:00 2511

Five-Year Plans: A Key Approach of the CPC's Governance of China

BEIJING, Nov. 24, 2025 /PRNewswire/ -- A news report from en.qstheory.cn Formulating medium- and long-term plans to guide economic and social development is an important approach with which the Communist Party ofChina (CPC) governs the country. AsChina's most important medium- and long-term plan...

2025-11-24 17:28 663

Ping An Unveils "Ancient Tree Guardian Action" at UN Climate Change Conference (COP30)

Leveraging an Innovative "Insurance + Technology" Approach to Safeguard 55,000 Ancient Trees and Promote Biodiversity Conservation HONG KONG and SHANGHAI, Nov. 24, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. ("Ping An" or "the Group", HKEX: 2318/82318; SSE: 601318) prese...

2025-11-24 17:06 2091

Chingdailyhk.com:Yunnan's culture and tourism charm shine in Thailand

AYUTTHAYA, Thailand, Nov. 24, 2025 /PRNewswire/ -- Southwest China's Yunnan province attracted numerous Thais and foreign travelers for its stunning scenery and its rich tapestry of ethnic cultures on Sunday atThailand's historical city Ayutthaya.

2025-11-24 16:46 806

Chingdailyhk.com: Marathon event held for enduring partnership

AYUTTHAYA, Thailand, Nov. 24, 2025 /PRNewswire/ -- Runners worldwide gathered in Thailand's Ayutthaya on Sunday for the Ayutthaya Marathon 2025, launched with a grand cultural ceremony marking 50 years of Sino-Thai diplomatic relations. Runners...

2025-11-24 16:41 793

PONY AI Inc. Partners with Sunlight Mobility to Adopt an Asset-Light Model for Accelerating Fleet Expansion

GUANGZHOU, China, Nov. 24, 2025 /PRNewswire/ -- Pony AI Inc. ("Pony.ai" or the "Company") (NASDAQ: PONY) (HKEX: 2026), a global leader in the commercialization of autonomous mobility, today announced an expanded partnership with Sunlight Mobility to implement an asset-light model. This marks a s...

2025-11-24 16:30 1080

CKGSB Celebrates 23rd Anniversary with Unveiling of First Permanent Beijing Campus

BEIJING, Nov. 24, 2025 /PRNewswire/ -- Cheung Kong Graduate School of Business (CKGSB) celebrates its 23rd anniversary with the unveiling of its first permanentBeijing campus. For the first time since its founding on November 21, 2002, the school will have a permanent home — a space that represen...

2025-11-24 16:02 784

GAC Launches "Four Growth Engines" to Build a New GAC at 2025 Guangzhou Auto Show

GUANGZHOU, China, Nov. 24, 2025 /PRNewswire/ -- On November 21, the 23rd Guangzhou International Automobile Exhibition opened at the Canton Fair Complex. At this year's show, GAC presented the key achievements of the "Panyu Action" one year after its launch, marking significant progress in organ...

2025-11-24 14:02 787

ProPak Shenzhen 2025: Intelligent Technology, Future Packaging

SHENZHEN, China, Nov. 24, 2025 /PRNewswire/ -- Under the rapid transformation and expanding consumer demand of the food industry in the Guangdong–Hong Kong–Macao Greater Bay Area, ProPak Shenzhen 2025 will take place from December 16 to 18 at the Shenzhen World Exhibition & Convention Center (Bao...

2025-11-24 10:00 943

Xinhua Silk Road: Chinese county Dehua stages Blanc de Chine-themed exhibition in Los Angeles

BEIJING, Nov. 24, 2025 /PRNewswire/ -- After the New York leg in March 2024, the "Blanc de Chine • Porcelain from Dehua" international itinerant exhibition opened inthe United States again on November 20. Fang Junqin, Party Chief of Dehua Coun...

2025-11-24 09:35 963

Harbour BioMed Advances Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Biotherapeutics in Oncology

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 23, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics for immunology and oncology, today announced an u...

2025-11-24 08:01 1201
1 ... 19202122232425 ... 1713

Week's Top Stories